Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03643549
Brief Title: Bortezomib and Temozolomide in Recurrent Glioblastoma With Unmethylated MGMT Promoter (BORTEM-17) (BORTEM-17)

First Submitted : August 21, 2018
First Submitted that Met QC Criteria : August 21, 2018
First Posted : August 22, 2018

Last Update Submitted that Met QC Criteria : August 31, 2018
Last Update Posted : September 3, 2018 (Estimate)